First Trust Advisors’s Guardant Health GH Stock Holding History

First Trust Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.7M	Sell	118,200 -17,738	-13%	-$1.93M	0.01%	974
2026 Q1	$12.6M	Sell	135,938 -43,793	-24%	-$4.4M	0.01%	1014
2025 Q4	$18.4M	Sell	179,731 -6,462	-3%	-$578K	0.01%	899
2025 Q3	$11.6M	Sell	186,193 -16,052	-8%	-$873K	0.01%	1052
2025 Q2	$10.5M	Sell	202,245 -12,046	-6%	-$538K	0.01%	1067
2025 Q1	$9.13M	Buy	214,291 +157,568	+278%	+$6.8M	0.01%	1078
2024 Q4	$1.73M	Sell	56,723 -50,951	-47%	-$1.43M	﹤0.01%	1860
2024 Q3	$2.47M	Buy	+107,674	New	+$3.05M	﹤0.01%	1684
2023 Q4	–	Sell	-79,916	Closed	-$2.37M	–	2375
2023 Q3	$2.37M	Buy	+79,916	New	+$2.81M	﹤0.01%	1615
2023 Q1	–	Sell	-122,947	Closed	-$3.34M	–	2402
2022 Q4	$3.34M	Buy	+122,947	New	+$5.63M	﹤0.01%	1445
2022 Q2	–	Sell	-24,392	Closed	-$1.62M	–	2531
2022 Q1	$1.62M	Buy	24,392 +15,873	+186%	+$1.09M	﹤0.01%	1851
2021 Q4	$852K	Sell	8,519 -10,445	-55%	-$1.08M	﹤0.01%	2120
2021 Q3	$2.37M	Sell	18,964 -207,040	-92%	-$24.6M	﹤0.01%	1702
2021 Q2	$28.1M	Sell	226,004 -62,565	-22%	-$8.42M	0.03%	638
2021 Q1	$44M	Sell	288,569 -41,877	-13%	-$6.33M	0.05%	462
2020 Q4	$42.6M	Buy	330,446 +247,291	+297%	+$28.5M	0.06%	451
2020 Q3	$9.29M	Sell	83,155 -231,369	-74%	-$21.2M	0.01%	764
2020 Q2	$25.5M	Sell	314,524 -1,554	-0.5%	-$125K	0.04%	488
2020 Q1	$22M	Buy	+316,078	New	+$24.3M	0.05%	474
2019 Q4	–	Sell	-80,251	Closed	-$5.12M	–	2412
2019 Q3	$5.12M	Buy	80,251 +7,058	+10%	+$622K	0.01%	1049
2019 Q2	$6.32M	Buy	73,193 +1,322	+2%	+$101K	0.01%	941
2019 Q1	$5.51M	Buy	71,871 +264	+0.4%	+$14.6K	0.01%	973
2018 Q4	$2.69M	Buy	+71,607	New	+$2.64M	0.01%	1299

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

First Trust Advisors's GH Position: Q2 2026 in Review

First Trust Advisors reduced its Guardant Health (GH) stake by 13% in Q2 2026, selling an estimated $1.93M and leaving 118,200 shares worth $17.7M. The position accounts for 0.01% of the portfolio, ranked #974.

First Trust Advisors first reported a position in GH in Q4 2018 and has held it in 23 quarters since. The position peaked at $44M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

First Trust Advisors held 118,200 shares of Guardant Health worth $17.7M as of Q2 2026.
First Trust Advisors sold 17,738 Guardant Health shares in Q2 2026, an estimated $1.93M.
Guardant Health made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #974 holding.
First Trust Advisors first reported a position in Guardant Health in Q4 2018 and has held it in 23 quarters since.
First Trust Advisors's Guardant Health position peaked at $44M in Q1 2021.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.